A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
Janssen Research & Development, LLC
Janssen Research & Development, LLC
University of California, San Francisco
Northwestern University
National Institutes of Health Clinical Center (CC)